According to Zhitong Finance App News, Liaoning Chengda (600739.SH) issued an announcement. In order to better implement the company's strategic plan and seize investment opportunities in the biomedical sector in a timely manner, Chengda Steel Hong Kong, a wholly-owned subsidiary of the company, plans to invest 5 million US dollars as a limited partner to subscribe to the fund share of Likon Venture Fund II Limited Partnership (Cayman) (“Target Fund” for short).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.